Curis (CRIS) Other Working Capital Changes (2010 - 2026)
Curis (CRIS) reported Other Working Capital Changes of $126000.0 for Q1 2026, up 115.27% on a YoY basis from $58530.4 in Q1 2025, and up 108.02% quarter-over-quarter from -$1.6 million in Q4 2025.
Curis (CRIS) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Curis has reported Other Working Capital Changes for 17 years, with the latest figure at $126000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 115.27% year-over-year to $126000.0; the trailing twelve-month figure through Mar 2026 stood at -$621000.0 (up 82.85% YoY), and the FY2025 full-year result was -$1.6 million, down 13.67% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $126000.0, up from -$1.6 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.5 million in Q4 2022, with the low at -$1.7 million in Q4 2024.
- Historically, Other Working Capital Changes has averaged -$37333.3 across 5 years, with a median of -$29000.0 in 2025.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes sank 281.78% — and 2025, when it surged 266.47%.
- Curis' Other Working Capital Changes stood at $2.5 million in 2022, then plunged by 58.41% to $1.0 million in 2023, then tumbled by 261.11% to -$1.7 million in 2024, then advanced by 4.9% to -$1.6 million in 2025, then jumped by 108.02% to $126000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $126000.0 (Q1 2026), -$1.6 million (Q4 2025), and $854000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126,000.00 |
| Mar 31, 2026 | 126,000.00 |
| Dec 31, 2025 | -1.57 Mn |
| Dec 31, 2025 | -1.57 Mn |
| Sep 30, 2025 | 854,000.00 |
| Sep 30, 2025 | 854,000.00 |
| Jun 30, 2025 | -29,000.00 |
| Jun 30, 2025 | -29,000.00 |
| Mar 31, 2025 | -825,000.00 |
| Mar 31, 2025 | -825,000.00 |
| Dec 31, 2024 | -1.65 Mn |
| Dec 31, 2024 | -1.65 Mn |
| Sep 30, 2024 | -513,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -630,000.00 |
| Jun 30, 2024 | -630,000.00 |
| Mar 31, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Sep 30, 2023 | 1.03 Mn |